Replies to post #772875 on NorthWest Biotherapeutics Inc (NWBO)

[FeMike]

I don't know how many brain surgeries are done in LA in a year, but I don't believe that it's more than a few hundred a year. I would suspect that UCLA, or City of Hope, or others in LA could handle perhaps 10 units, each capable of 50 batches of vaccine, or 500 batches a year. Probably all that's needed for the Greater LA area for brain cancers alone. Of course, if the vaccine is labeled tumor agnostic, then the numbers would need to increase dramatically. I don't believe it would be a problem within all the fine medical facilities located in the greater LA area.

Ah, so your argument is that the UK is delaying the approval of DCVax-L until their regulation, a British regulation which has no impact on the US, is in place. Even though NWBO currently has capacity to supply the UK. So that Los Angeles can manufacture DCVax in its hospitals. Which is a product that hasn’t been approved or applied for approval in the US. Got it.

That makes sense. How nice of the Brits.